{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:23:33Z","timestamp":1777429413086,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ghir.2004.03.033","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T06:36:08Z","timestamp":1084257368000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S","title":["Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2)"],"prefix":"10.1016","volume":"14","author":[{"given":"Camilo","family":"Jimenez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Gagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2004.03.033_BIB1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-9343(61)90234-0","article-title":"The association of pheochromocytoma with carcinoma of the thyroid gland","volume":"31","author":"Sipple","year":"1961","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ghir.2004.03.033_BIB2","series-title":"Book Multiple Endocrine Neoplasia","first-page":"1762","article-title":"Multiple endocrine neoplasia","author":"Gagel","year":"2003"},{"key":"10.1016\/j.ghir.2004.03.033_BIB3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-111-10-802","article-title":"Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis","volume":"111","author":"Gagel","year":"1989","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.ghir.2004.03.033_BIB4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2265.1989.tb03727.x","article-title":"Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome)","volume":"30","author":"Nunziata","year":"1989","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.03.033_BIB5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/bjs.1800730411","article-title":"Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity","volume":"73","author":"Farndon","year":"1986","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ghir.2004.03.033_BIB6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.1700910109","article-title":"Multiple mucosal neuromata with endocrine tumours: a syndrome allied to Von Recklinghausen's disease","volume":"9l","author":"Williams","year":"1966","journal-title":"J. Pathol. Bacteriol."},{"key":"10.1016\/j.ghir.2004.03.033_BIB7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archinte.1992.00400180104016","article-title":"The natural course of multiple endocrine neoplasia type IIb: a study of 18 cases","volume":"152","author":"Vasen","year":"1992","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.ghir.2004.03.033_BIB8","first-page":"236","article-title":"Multiple endocrine neoplasia type 2B: eighteen-year follow-up of a four-generation family","volume":"40","author":"Sizemore","year":"1992","journal-title":"Henry Ford Hosp. J."},{"key":"10.1016\/j.ghir.2004.03.033_BIB9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-19-1-152","article-title":"Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity","volume":"19","author":"Hazard","year":"1959","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.19.2.114","article-title":"Histogenesis of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ghir.2004.03.033_BIB11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jcp.19.2.103","article-title":"Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ghir.2004.03.033_BIB12","first-page":"399","article-title":"Studies in familial (medullary) thyroid carcinoma","volume":"28","author":"Melvin","year":"1972","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.ghir.2004.03.033_BIB13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM197811022991804","article-title":"Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis","volume":"299","author":"Graze","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.03.033_BIB14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJM198802253180804","article-title":"The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a: An 18-year experience","volume":"318","author":"Gagel","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.03.033_BIB15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ghir.2004.03.033_BIB16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2004.03.033_BIB17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2004.03.033_BIB18","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB19","first-page":"1700","article-title":"A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma","volume":"84","author":"Pigny","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB20","first-page":"770","article-title":"A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A","volume":"83","author":"Berndt","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB21","first-page":"1157","article-title":"A new inherited RET proto-oncogene mutation associated with familial medullary thyroid carcinoma and polymorphisms in adjacent regions (published erratum appears in Genetika 1999 Jan;35(1):116)","volume":"34","author":"Kalinin","year":"1998","journal-title":"Genetika"},{"key":"10.1016\/j.ghir.2004.03.033_BIB22","first-page":"4176","article-title":"A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma","volume":"82","author":"Hofstra","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/mcpr.1998.0220","article-title":"A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy","volume":"13","author":"Dang","year":"1999","journal-title":"Mol. Cell Probes."},{"key":"10.1016\/j.ghir.2004.03.033_BIB24","first-page":"3740","article-title":"Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma","volume":"81","author":"Wohllk","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/gcc.2870120308","article-title":"Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma","volume":"12","author":"Eng","year":"1995","journal-title":"Gene Chromosome Canc."},{"key":"10.1016\/j.ghir.2004.03.033_BIB26","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/3.10.1895","article-title":"RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer","volume":"3","author":"Blaugrund","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ghir.2004.03.033_BIB27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/3.8.1259","article-title":"Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs","volume":"3","author":"Zedenius","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ghir.2004.03.033_BIB28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jmg.32.12.934","article-title":"Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas","volume":"32","author":"Eng","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ghir.2004.03.033_BIB29","first-page":"4101","article-title":"Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene","volume":"82","author":"Brauch","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.03.033_BIB30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1997.3251150.x","article-title":"Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes","volume":"47","author":"Bar","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2004.03.033_BIB31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","article-title":"Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection","volume":"229","author":"Moley","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ghir.2004.03.033_BIB32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00000658-199911000-00013","article-title":"Surgical strategy for the treatment of medullary thyroid carcinoma","volume":"230","author":"Fleming","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ghir.2004.03.033_BIB33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.1995.tb01207.x","article-title":"Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A","volume":"238","author":"Gagel","year":"1995","journal-title":"J. Int. Med."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:39:52Z","timestamp":1761086392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637404000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":33,"alternative-id":["S1096637404000644"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2004.03.033","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2)","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2004.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}